Home › Liver Cancer (Hepatocellular Carcinoma) › Oklahoma
Liver Cancer (Hepatocellular Carcinoma) clinical trials in Oklahoma
5 studies for Liver Cancer (Hepatocellular Carcinoma) are looking for participants at sites in Oklahoma.
Cities in Oklahoma
The Vanguard Study: Testing a New Way to Screen for Cancer
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingHealthy volunteers welcome
Ages 45 to 75 · All sexes · Updated Oct 5, 2026 · NCT06995898Phase III Study of Rilvegostomig in Combination With Bevacizumab With or Without Tremelimumab as First-line Treatment of Hepatocellular Carcinoma
- Research Site, Oklahoma City
RecruitingPhase 3
Ages 18 and older · All sexes · Updated Sep 3, 2026 · NCT06921785A Study of TTI-101 as Monotherapy and in Combination in Participants With Locally Advanced or Metastatic, and Unresectable Hepatocellular Carcinoma
- University of Oklahoma Health Sciences Center, Oklahoma City
RecruitingPhase 1/2
Ages 18 and older · All sexes · Updated Apr 27, 2026 · NCT05440708Combination of TATE and PD-1 Inhibitor in Liver Cancer
- University of Oklahoma Health Science Center, Oklahoma City
RecruitingPhase 2
Ages 18 to 80 · All sexes · Updated Apr 16, 2026 · NCT03259867SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Tulsa
RecruitingObservational study
All ages · All sexes · Updated Oct 28, 2025 · NCT03452774From ClinicalTrials.gov, data retrieved Oct 6, 2026. Each study sets its own eligibility; the study team decides who can join.